ALK and neuroblastoma: The failure of Th-Cre mediated deletion of Atrx to drive murine neuroblastoma is consistent with experiments in the Th-ALK models [19] and it is likely that additional oncogenic drivers will be required to generate murine ATRX mutant neuroblastoma models.